Cibus Inc. (CBUS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cibus Inc. (CBUS:NASDAQ), powered by AI.

Current Price
$1.23
Sector
Healthcare
What is the Cibus Inc. stock price forecast?

Cibus Inc. is currently trading at $1.23. View real-time AI analysis on Alpha Lenz.

What is Cibus Inc. insider trading activity?

View the latest insider trading data for Cibus Inc. on Alpha Lenz.

What is Cibus Inc.'s P/E ratio?

View Cibus Inc.'s valuation metrics on Alpha Lenz.

Cibus Inc.

NASDAQ · CBUS
$1.23-0.02(-1.60%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Cibus Inc.'s future dividend policy...
Alpha Chat Insight

Cibus Inc.'s ROE is -223.0%. Explore profitability and growth together.

Ask for details

Company Overview

Cibus Inc., a leading company within the bioscience sector, focuses on developing and commercializing sustainable agricultural solutions. The primary function of Cibus lies in its innovative gene-editing technology aimed at enhancing plant traits, thereby improving crop yield, resilience, and overall sustainability. Cibus leverages its proprietary Rapid Trait Development System (RTDS) to address food security and agricultural efficiency, making it a key player in the production of non-GMO, improved crop varieties. These advancements cater to a variety of industries, notably agriculture and food production, promoting sustainable practices aligned with global environmental strategies. Headquartered in the biotech hub of San Diego, Cibus collaborates with seed companies and agricultural producers worldwide, providing solutions that respond to the ongoing demand for increased agricultural productivity without compromising environmental concerns. By playing a crucial role in modern crop management, Cibus Inc. supports the drive towards a more sustainable and efficient agricultural economy, contributing significantly to the evolving landscape of global food supply and security.

CEODr. Peter R. Beetham B.Sc., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees157

Company Statistics

FY 2025

Profile

N/AMarket Cap
$3.64MRevenue
0.00Shares Out
157Employees

Margins

100.00%Gross
-1668.12%EBITDA
-1853.92%Operating
-3632.10%Pre-Tax
-3632.89%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

185.12%Rev 3Yr
-31.34%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-40.36%ROA
-222.98%ROE
-29.52%ROIC

Financial Health

$9.92MCash & Cash Equivalents
$273.30MNet Debt
1297.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cibus Inc. (ticker: CBUS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 157 employees.

The current price is $1.23 with a P/E ratio of -x and P/B of -x.

ROE is -222.98% and operating margin is -1853.92%. Annual revenue is $4M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cibus Inc. (CBUS) Stock Forecast 2026 $1.23 — Price, Financials & Analyst Targets | Alpha Lenz